Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease

Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease

Alzheimer's disease (AD) is a heterogeneous neurodegenerative disease, with no standard biomarker(s) to detect or confirm its risk at an early stage. The prevalence of AD increases exponentially worldwide in people of ages over 65 and older. Current improvements have unveiled the disease's...

Full description

Saved in:
Bibliographic Details
Main Authors: Tapas K. Sur, Tanmoy Mondal, Zarish Noreen, Jheannelle Johnson, Gail Nunlee-Bland, Christopher A. Loffredo, Brent E. Korba, Vijay Chandra, Siddhartha S. Jana, Bernard Kwabi-Addo, Sumit Sarkar, Somiranjan Ghosh
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Biomarkers in Neuropsychiatry
Subjects:
Alzheimer’s Disease
β-amyloid
tau
APOE
Transcriptome analysis
Blood Biomarkers
Online Access:http://www.sciencedirect.com/science/article/pii/S2666144625000024
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items